Andrew Kuykendall, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie, Blueprint Medicines, Celgene/BMS, CTI Biopharma, DISC Medicine, ​ Geron, GSK, Incyte, Karyopharm, MorphoSys, Novartis, PharmaEssentia, Protagonist, Silence Therapeutics, Takeda
    Date added:
    09/20/2025
    Date updated:
    09/20/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    AJAX, Blueprint Medicines, BMS, Geron, GSK, Janssen, Kartos, MorphoSys, Novartis, Protagonist​
    Date added:
    09/20/2025
    Date updated:
    09/20/2025
Return to 2025 National Summit on Hematologic Cancers